ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2323

Exploring HLA-DRB1 Risk Alleles in Non-Hispanic African American Children with Juvenile Idiopathic Arthritis and Chronic Anterior Uveitis

Lai Hin Kimi Chan1, Courtney McCracken1, Kirsten Jenkins2, Steven Yeh3, Purnima Patel4, Sampath Prahalad5 and Sheila Angeles-Han6, 1Pediatrics, Emory University School of Medicine, Atlanta, GA, 2Children's Healthcare of Atlanta, Atlanta, GA, 3Ophthalmology, Emory University School of Medicine, Atlanta, GA, 4Emory University School of Medicine, Atlanta, GA, 5Pediatrics, Emory Children's Center, Atlanta, GA, 6Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: genetics, Juvenile idiopathic arthritis (JIA) and uveitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Pediatric Rheumatology – Pathogenesis and Genetics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Exploring HLA-DRB1 Risk Alleles in Non-Hispanic African American Children with Juvenile Idiopathic Arthritis and Chronic Anterior Uveitis

Background/Purpose:
HLA-DRB1*08, 11 and 13 are risk alleles associated with juvenile idiopathic arthritis (JIA). Carriage of DRB1*11 and *13 may increase the risk for uveitis in Non-Hispanic White children with oligoarticular and polyarticular rheumatoid factor (RF) negative JIA. HLA-B8, in linkage disequilibrium with DRB1*03, was reported in African American children with uveitis. Few studies investigate the role of HLA-DRB1 alleles in Non-Hispanic African American (NH AA) children with JIA or uveitis because they are rare conditions. Our aim is to explore the association of HLA-DRB1 alleles in NH AA children with JIA and chronic anterior uveitis (CAU). 

Methods:
High-resolution HLA-DRB1 genotyping was performed to determine the frequency of HLA-DRB1*03, 08,11 and 13 alleles in our cohort of NH AA children with JIA and/or uveitis. Frequencies were compared among JIA and CAU (JIA-associated uveitis and idiopathic chronic anterior uveitis) groups using Chi-square tests and Exact tests. In addition, we compared the frequency of these alleles in our cohorts to 3734 AA healthy controls from the National Marrow Donor Program (NMDP) using two-sided Z-tests for proportions.

Results:
There were 58 NH AA children (43 JIA, 6 JIA-associated uveitis, and 9 idiopathic chronic anterior uveitis) who were mainly female (66%). Of those with JIA, 22 (45%) had extended or persistent oligoarticular JIA, and 27 (55%) had polyarticular RF negative JIA. Antinuclear antibody was positive in 17 (40%) JIA children and 3 (50%) JIA-associated uveitis (JIA-U) children.

Comparing children with JIA and CAU, there was a borderline significant difference in DRB1*03 (30.2% vs. 6.7%, p = 0.087) (Table 1).

Compared to AA controls, NH AA children with JIA alone had increased DRB1*03 (30.2% vs. 13.6%, p = 0.001), DRB1*08 (18.6% vs. 3.3%), and DRB1*11 (32.6% vs. 13.4%, p < 0.001). NH AA children with CAU (JIA-U and idiopathic chronic anterior uveitis) also had increased DRB1*08 (13.3% vs. 3.3%, p = 0.029) and DRB1*11 (46.7% vs. 13.4%, p < 0.001), which may be associated with the JIA diagnosis (Table 2).

Conclusion:
Carriage of HLA-DRB1*08 and 11 may increase the risk for JIA and uveitis in NH AA children. Carriage of DRB1*03 may also increase the risk for JIA in this cohort. Further studies including larger sample sizes of NH AA children should be conducted to investigate the role of HLA-DRB1 in children with JIA and uveitis.

Description: Macintosh HD:Users:kimichan:Desktop:Screen Shot 2017-06-18 at 10.35.13 PM.png Description: Macintosh HD:Users:kimichan:Desktop:Screen Shot 2017-06-18 at 10.35.54 PM.png


Disclosure: L. H. K. Chan, None; C. McCracken, None; K. Jenkins, None; S. Yeh, None; P. Patel, None; S. Prahalad, None; S. Angeles-Han, None.

To cite this abstract in AMA style:

Chan LHK, McCracken C, Jenkins K, Yeh S, Patel P, Prahalad S, Angeles-Han S. Exploring HLA-DRB1 Risk Alleles in Non-Hispanic African American Children with Juvenile Idiopathic Arthritis and Chronic Anterior Uveitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/exploring-hla-drb1-risk-alleles-in-non-hispanic-african-american-children-with-juvenile-idiopathic-arthritis-and-chronic-anterior-uveitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-hla-drb1-risk-alleles-in-non-hispanic-african-american-children-with-juvenile-idiopathic-arthritis-and-chronic-anterior-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology